Japan Blood Disease Industry Outlook 2022 - 2026

See how Japan Blood Disease performed compared to key markets such as Germany and Italy.

Key Market Indicators

Japanese Blood and Blood Forming Organs Medicine sales are projected to reach $6.7 billion by 2026. In 2021, the sales were estimated to be $5.9 billion, growing at a rate of 2% annually. Since 1985, the Japanese market has grown 8.7% year on year. Germany, Italy, and South Korea are the second, third and fourth biggest markets, respectively.

Japan Blood Disease Market Data and Forecasts

Japan Blood Disease : how will it grow in the coming years?

Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
Forecast: Prevalence of Anemia in Japan
Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
Forecast: Anaemia Prevalence in Japan
Forecast: Anemia Prevalence Among Pregnant Women in Japan
Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
Forecast: Blood and Blood Forming Organs Medicine Sales in Japan
View More

Other Top Countries about Blood Disease